Chengdu Biological City Equity Investment Fund

Guosheng Capital aims to become "the most influential comprehensive financial service provider in China's biotechnology industry." Its goal is to promote the establishment and strengthening of the biopharmaceutical industry chain. It has built a professional investment system based on a "three-in-one" business development model of "equity + debt + comprehensive financial services." The company carries out investment work and project evaluation following the working paradigm of "two fulls and three haves" (full regional coverage, full life cycle coverage, with analysis, with planning, with results), continuously improving and perfecting the financial cooperation ecosystem of BioCity. By leveraging financial capital to cultivate industrial ecosystem advantages, it supports the establishment and strengthening of the biotechnology industry chain, and promotes the growth and momentum of the biotechnology industry.Since its official operation in 2020, the company has established five sub-funds, with a total fund size exceeding 7 billion yuan, and has completed nearly 50 project investments.